![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | (2006.01) |
C07K 16/18 | (2013.01) | ||
A61K 39/00 | (2006.01) | ||
A61K2039/505 | (2013.01) | ||
C07K 16/18 | (2006.01) | ||
A61K2039/54 | (2013.01) | ||
C07K 16/40 | (2006.01) | ||
A61K2039/545 | (2013.01) | ||
C07K2317/76 | (2013.01) | ||
A61P 9/00 | (2018.01) | ||
A61P 37/06 | (2018.01) |
(11) | Number of the document | 3368073 |
(13) | Kind of document | T |
(96) | European patent application number | 16791271.6 |
Date of filing the European patent application | 2016-10-28 | |
(97) | Date of publication of the European application | 2018-09-05 |
(45) | Date of publication and mention of the grant of the patent | 2024-05-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/059279 |
Date | 2016-10-28 |
(87) | Number | WO 2017/075325 |
Date | 2017-05-04 |
(30) | Number | Date | Country code |
201562248873 P | 2015-10-30 | US | |
201662321632 P | 2016-04-12 | US |
(72) |
POBER, Jordan , US
JANE-WIT, Daniel , US
QIN, Lingfeng , US
WANG, Yi , US
|
(73) |
Alexion Pharmaceuticals, Inc. ,
100 College Street, New Haven, CT 06510,
US
Yale University , Two Whitney Avenue, New Haven, CT 06510, US |
(54) | A METHOD OF INHIBITING EXACERBATIONS OF T CELL-MEDIATED ALLOGRAFT VASCULOPATHY |
A METHOD OF INHIBITING EXACERBATIONS OF T CELL-MEDIATED ALLOGRAFT VASCULOPATHY |